Table 1. The DNA content of THP-1 cells in PMA administration for 5 days.
control | TM si RNA | HA-TM FL | PMA administration for 5 days |
|||
---|---|---|---|---|---|---|
— | TM si RNA | HA-TM FL | ||||
G0/G1 phase | 19.6 ± 2.8% | 20.5 ± 3.2% | 18.7 ± 3.1% | 70.3 ± 2.9%* | 47.3 ± 3.7%† | 84.1 ± 1.9%*† |
S phase | 58.9 ± 6.2% | 54.2 ± 5.0% | 53.4 ± 7.0% | 8.9 ± 3.1%* | 29.7 ± 5.2%† | 11.2 ± 3.5%* |
G2/M phase | 16.2 ± 8.8% | 25.3 ± 9.1% | 27.9 ± 3.4% | 10.6 ± 0.8%* | 6.2 ± 1.0%* | 4.5 ± 1.9%* |
(n = 5). *p < 0.05 compared to control group; †p < 0.05 compared to PMA-administrated group.